VAERS reports by lot

Merck Pneumococcal lot N020502: VAERS reports

80 VAERS reports list lot N020502 as a Merck Pneumococcal vaccine, received between 2017-09-28 and 2021-07-27. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
80
Reports
4%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction10844%
General / Systemic (non-local)3213%
Allergic / Anaphylactic2811%
Dermatological (non-injection-site)239%
Musculoskeletal198%
Neurological125%
Gastrointestinal104%
Psychiatric / Neuropsychiatric62%
Cardiac / Cardiovascular42%
Respiratory21%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York8
Pennsylvania6
Florida5
Virginia4
Tennessee4
Idaho3
Ohio3
Kansas3
North Carolina3
Texas3
Missouri2
Utah2

Reports by month received

2017-092
2017-1034
2017-116
2017-1210
2018-014
2018-021
2018-033
2018-043
2018-054
2018-073
2018-092
2018-105
2018-111
2019-121
2021-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.